Waters and Wyatt Collaborate to Advance Polymer Analysis and Biopharmaceutical Characterization Studies
Coupling of technologies delivers valuable information 5x faster than conventional size exclusion chromatography (SEC) MILFORD, Mass.–(BUSINESS WIRE)–May 31, 2017– Waters Corporation (NYSE:WAT) announced that it entered into a Co-Marketing agreement with Wyatt Technology to advance the analysis of synthetic polymers and biotherapeutic proteins. By pairing Waters® ACQUITY® UPLC® and Waters® ACQUITY® Advanced Polymer Chromatography® (APC™)... Read more